Cargando…

The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup

Detalles Bibliográficos
Autores principales:	Brooks, Philip J., Ottinger, Elizabeth A., Portero, Deanna, Lomash, Richa Madan, Alimardanov, Asaf, Terse, Pramod, Xu, Xin, Chandler, Randy J., Hauserman, Janelle Geist, Esposito, Eric, Bönnemann, Carsten G., Venditti, Charles P., Austin, Christopher P., Pariser, Anne, Lo, Donald C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2020
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585601/ https://www.ncbi.nlm.nih.gov/pubmed/32993373 http://dx.doi.org/10.1089/hum.2020.259

Ejemplares similares

Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience
por: Lomash, Richa Madan, et al.
Publicado: (2023)

Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia
por: May, Francis J., et al.
Publicado: (2021)

Long-term Rescue of a Lethal Murine Model of Methylmalonic Acidemia Using Adeno associated Viral Gene Therapy
por: Chandler, Randy J, et al.
Publicado: (2009)

Systemic gene therapy for methylmalonic acidemia using the novel adeno-associated viral vector 44.9
por: Chandler, Randy J., et al.
Publicado: (2022)

Adeno-Associated Virus Gene Therapy for Liver Disease
por: Kattenhorn, Lisa M., et al.
Publicado: (2016)

Gene therapy for metabolic diseases
por: Chandler, Randy J., et al.
Publicado: (2016)

My Pathway to Adeno-Associated Virus and Adeno-Associated Virus Gene Therapy: A Personal Perspective
por: Carter, Barrie J.
Publicado: (2020)

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues
por: Chandler, Laurel C., et al.
Publicado: (2019)

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues
por: Chandler, Laurel C., et al.
Publicado: (2023)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
por: Hocquemiller, Michaël, et al.
Publicado: (2016)

Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
por: Bastola, Prabhakar, et al.
Publicado: (2020)

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
por: Xu, Xin, et al.
Publicado: (2021)

The state of the art of adeno-associated virus-based vectors in gene therapy
por: Coura, Renata dos Santos, et al.
Publicado: (2007)

Correction: The state of the art of adeno-associated virus-based vectors in gene therapy
por: dos Santos Coura, Renata, et al.
Publicado: (2010)

Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases
por: Zhou, Kai, et al.
Publicado: (2022)

Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy
por: Gorovits, Boris, et al.
Publicado: (2023)

Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
por: Zhao, Liyuan, et al.
Publicado: (2023)

Survey of startup
Publicado: (1981)

Startup CEO
por: Blumberg, Matt
Publicado: (2020)

Startup Communities
por: Feld, Brad
Publicado: (2020)

The Startup Playbook
por: Bhargava, Rajat, et al.
Publicado: (2020)

The accidental startup
por: Babb, Danielle
Publicado: (2009)

LHC Startup
por: Smith, Wesley H
Publicado: (2008)

Startup Accelerators
por: Busulwa, Richard, et al.
Publicado: (2020)

Advancements in adeno-associated viral gene therapy approaches: exploring a new horizon
por: Aalbers, Caroline J., et al.
Publicado: (2011)

Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)

An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy
por: Duncan, Gregg A., et al.
Publicado: (2018)

Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
por: Qu, Yuan, et al.
Publicado: (2019)

The Application of Adeno-Associated Viral Vector Gene Therapy to the Treatment of Fragile X Syndrome
por: Hampson, David R., et al.
Publicado: (2019)

Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectors
por: Hösel, Marianna, et al.
Publicado: (2017)

Ocular Gene Therapy with Adeno-associated Virus Vectors: Current Outlook for Patients and Researchers
por: Casey, Geoffrey A., et al.
Publicado: (2020)

Structure of the gene therapy vector, adeno-associated virus with its cell receptor, AAVR
por: Meyer, Nancy L, et al.
Publicado: (2019)

Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia
por: Monahan, Paul E., et al.
Publicado: (2021)

Harnessing the Natural Biology of Adeno-Associated Virus to Enhance the Efficacy of Cancer Gene Therapy
por: Bower, Jacquelyn J., et al.
Publicado: (2021)

Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
por: Kotulska, Katarzyna, et al.
Publicado: (2021)

Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry
por: Wu, Di, et al.
Publicado: (2022)

Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy
por: Guillou, Julia, et al.
Publicado: (2022)

Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis
por: Bu, Fang-tian, et al.
Publicado: (2022)

Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
por: Ail, Divya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_distuhb443dlpgrkid4baaa1nl